• / Free eNewsletters & Magazine
  • / My Account
Home>Juno Therapeutics prices IPO above expected range

Juno Therapeutics prices IPO above expected range

3party Content

Fri, 19 Dec 2014

Juno Therapeutics Inc. (JUNO) priced its initial public offering above the expected range late Thursday. Juno said it will offer 11 million shares at $24 apiece. The expected range on the IPO was $21 to $23 a share. Juno is a biotech company that is developing cancer therapies. Shares will begin
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.